Clinical Report: Identification of Distinct Subphenotypes in Severe ARDS Patients
Overview
This study identifies distinct subphenotypes in severe acute respiratory distress syndrome (ARDS) patients undergoing veno-venous extracorporeal membrane oxygenation (VV-ECMO) using data-driven clustering techniques. Key findings indicate significant differences in clinical outcomes based on inflammatory, renal, and hepatic dysfunctions among the identified subphenotypes, with survival rates of 32% and 21% in specific clusters.
Background
Acute respiratory distress syndrome (ARDS) presents a high mortality rate, often exceeding 50% in patients requiring VV-ECMO. The heterogeneity of ARDS complicates risk stratification and treatment monitoring, necessitating a refined approach to patient management. Identifying subphenotypes can enhance treatment strategies.
Data Highlights
Parameter
Cluster 1
Cluster 2
Cluster 3
Survival Rate
32%
21%
Data not specified
ICU Length of Stay
Longer
Shorter
Varied
Key Findings
Cluster analysis revealed distinct ARDS subphenotypes based on inflammation, renal/liver function, and coagulation parameters.
Survival rates varied significantly among clusters, particularly influenced by kidney/liver function.
Subphenotypes defined by ECMO or ventilator settings showed smaller differences in outcomes.
Clusters with multi-organ dysfunction had longer ICU stays.
Key differentiating parameters included procalcitonin, C-reactive protein, creatinine, and urea levels.
Clinical Implications
The identification of ARDS subphenotypes can inform risk stratification and management strategies in patients undergoing VV-ECMO.
Conclusion
Data-driven clustering of clinical parameters identifies ARDS subphenotypes in VV-ECMO patients, highlighting the importance of renal, hepatic, and inflammatory dysfunctions in survival outcomes.
A structured reporting tool improved report completeness, reduced classification errors, and achieved high physician adoption during routine lung cancer pathology reporting.